Psychiatry 18 , 582594 (2013)
Bayers 3.5 Billion Bet on What Others Abandoned At a media event in Spain, Benjamin Maino, Bayers Global Lead for Cell and Gene Therapy Product Supply, disclosed that the company has invested approximately 3.5 billion in the space, including acquisitions of BlueRock Therapeutics and Asklepios Biopharmaceutical
Ultimately, the obesity market will likely develop in a complex and unpredictable way, which will likely include both subcutaneous and oral products and combinations, with patients seeking cleaner side-effect profiles and becoming more averse to the ever-more publicized risks
Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR
So I kind of gave up on having white skin and decided to live with my current skin tone. Some in South Korea is starting to consider darker skin tones beautiful